Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
JMP Securities analyst Roy Buchanan maintains HOOKIPA Pharma (NASDAQ:HOOK) with a Market Outperform and raises the price tar...
JMP Securities analyst Jason Butler maintains HOOKIPA Pharma (NASDAQ:HOOK) with a Market Outperform and lowers the price tar...
Director Dr. Malte Peters named Chief Executive Officer and Director Terry Coelho named Executive Vice President and Chief Fina...
HOOKIPA Pharma shares are trading lower by 10.9% during Monday's session. The company announced a 1-for-10 reverse stock sp...
HOOKIPA Pharma Inc. (NASDAQ:HOOK, ", HOOKIPA", )))), a company developing a new class of immunotherapeutics based on it...
